Showing results (31-40 of 61) with videos related to
Sort By:
Pageof 7
Experimental Hematology|September 1, 2019
Evolution patterns of paroxysmal nocturnal hemoglobinuria clone and clinical implications in acquired bone marrow failureYu Lian, Jun Shi, Neng Nie, et al.Cytokine|February 26, 2022
Leptin-mediated proinflammatory bone marrow environment in acquired aplastic anemiaMengying Gao, Meili Ge, Jiali Huo, et al.Frontiers in Immunology|February 16, 2023
Association between human leukocyte antigen and immunosuppressive treatment outcomes in Chinese patients with aplastic anemiaLingyun Chen, Meili Ge, Jiali Huo, et al.Plos One|March 2, 2016
Impaired Autophagy in Adult Bone Marrow CD34+ Cells of Patients with Aplastic Anemia: Possible Pathogenic SignificanceJinbo Huang, Meili Ge, Shihong Lu, et al.Annals of Hematology|July 1, 2020
Long-term follow-up of a novel immunosuppressive strategy of cyclosporine alternatively combined with levamisole for severe aplastic anemiaJiali Huo, Xingxin Li, Yingqi Shao, et al.Nature Communications|August 27, 2024
Tyrosine phosphorylation of both STAT5A and STAT5B is necessary for maximal IL-2 signaling and T cell proliferationJian-Xin Lin, Meili Ge, Cheng-Yu Liu, et al.Cytokine|April 16, 2017
Pro-inflammatory effects of the Th1 chemokine CXCL10 in acquired aplastic anaemiaJunhong Li, Meili Ge, Shihong Lu, et al.Stem Cell Research & Therapy|August 3, 2017
CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemiaShihong Lu, Meili Ge, Yizhou Zheng, et al.Blood Science (Baltimore, Md.)|February 5, 2024
Predictive value of thyroid function in severe aplastic anemia patients treated with immunosuppressive therapyYilin Liu, Jiali Huo, Meili Ge, et al.Hemoglobin|September 4, 2019
Reticulocyte Hemoglobin Equivalent (Ret-He) Combined with Red Blood Cell Distribution Width Has a Differentially Diagnostic Value for ThalassemiasYu Lian, Jun Shi, Neng Nie, et al.Pageof 7